Biogen's blood disorder drug succeeds in late-stage trial
April 10, 2014 at 07:23 AM EDT
April 10 (Reuters) - Biogen Idec Inc and Swedish Orphan Biovitrum said their experimental blood disorder drug was effective in maintaining low bleeding rates in children in a late-stage trial.